any disease that produces malabsorption can bring about deficiencies of vitamins a d e and k

ATI RN

ATI Nutrition Practice A

1. Any disease that produces ____ malabsorption can bring about deficiencies of vitamins A, D, E, and K.

A. water
B. protein
C. fat
D. carbs

Correct answer: C

Rationale: Vitamins A, D, E, and K are fat-soluble, meaning they require fat for absorption. Diseases that cause fat malabsorption can lead to deficiencies in these vitamins.

2. Each statement is true of proteins, except one. Which is the exception?

A. Proteins are composed of building blocks called amino acids
B. The classification of the 20 common amino acids is based on the properties of their side chains
C. The general structure of an amino acid varies considerably
D. Amino acids polymerize to form long chains called polypeptides

Correct answer: B

Rationale: The correct answer is B. The classification of the 20 common amino acids is not based on the properties of their side chains, but rather on the structure of their amino and carboxyl groups. These groups are consistent among all amino acids, while the side chains, also known as R groups, are what vary and give each amino acid its unique properties. Choice A is correct because proteins are indeed composed of amino acids. Choice C is incorrect because while the side chains of amino acids can vary, the general structure of an amino acid - a central carbon atom bonded to an amino group, a carboxyl group, a hydrogen atom, and a side chain - is consistent. Choice D is correct because amino acids do polymerize to form long chains called polypeptides, which can then fold into complex shapes to form proteins.

3. Which factor contributes to the development of bone diseases in patients with Chronic Kidney Disease (CKD) due to retention?

A. Iron
B. Sodium
C. Potassium
D. Phosphorus

Correct answer: D

Rationale: The correct answer is phosphorus. Retention of phosphorus in patients with Chronic Kidney Disease (CKD) contributes to the development of bone disorders, including osteodystrophy, because it disrupts the balance of calcium and phosphorus in the body. This imbalance leads to a variety of bone diseases. The other options - iron, sodium, and potassium - while important in the overall metabolic function, are not directly linked to the development of bone diseases in CKD patients due to retention.

4. Which of the following is reflected in an ECG due to hypokalemia?

A. Tall T waves and Pathologic Q wave
B. Widening QRS Complex and U wave
C. None of the above
D. Both A and B

Correct answer: B

Rationale: Hypokalemia, a condition characterized by low levels of potassium in the blood, is reflected in an ECG by a widening QRS Complex and a U wave. This is because potassium plays a key role in the electrical activity of the heart, and its deficiency can lead to abnormalities in the heart's rhythm as represented by these specific changes on the ECG. Choice A is incorrect as tall T waves and pathologic Q waves are more commonly associated with hyperkalemia or myocardial infarction, respectively, rather than hypokalemia. Choices C and D are also incorrect as they do not accurately reflect the ECG changes caused by hypokalemia.

5. Medication for treating high blood cholesterol levels should not be used for most people unless:

A. The patient has at least three major risk factors for coronary heart disease
B. The patient has been experiencing symptoms of coronary heart disease for at least three months
C. The patient's medical insurance covers prescription drugs
D. Treatment with Therapeutic Lifestyle Changes (TLC) alone is unsuccessful after three months

Correct answer: D

Rationale: The correct answer is choice D because medication for high cholesterol is typically not considered unless Therapeutic Lifestyle Changes (TLC), which include diet and exercise, have not proven effective after a three-month period. This approach ensures that lifestyle modifications are given a fair chance to lower cholesterol levels before resorting to medication. Choice A is incorrect because the number of risk factors for coronary heart disease does not dictate when to begin medication; it is about the effectiveness of lifestyle changes. Choice B is incorrect as the duration of coronary heart disease symptoms does not determine when to start medication; the focus is on the response to TLC. Choice C is incorrect because the coverage of prescription drugs by the patient's insurance does not influence the medical decision to use medication for high cholesterol; it is based on medical necessity and effectiveness of prior interventions.